| Autor: |
Datta S; Scientist 'C', Biodefence & Biotechnology Division, Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India., Agarwal M; Graded Specialist (Pathology), Military Hospital Allahabad, C/o 56 APO, India., Chatterjee S; Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India., Gogoi HK; Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India., Veer V; Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India., Singh L; Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India. |
| Abstrakt: |
Human papillomavirus (HPV) associated cervical cancer is the leading cause of deaths in India. However, cytological/HPV screening may result in early detection of cervical cancer, resulting in early treatment and reduced mortality. Although reports related to general population is available, data on HPV prevalence among women attending AFMS health care facilities is scarce. Cervical samples were collected for cytological staining by Pap test and molecular detection by PCR, genotyping by HPV specific primers and sequencing. Apart from finding of atypical cells of undetermined significance (ASCUS) in one subject, no evidence of malignancy was observed. A high prevalence of HPV was found in this study group, which was intermediate between previous reports from general population and cervical cancer patients. All the subjects had infection of high risk HPV type16. HPV prevalence was found similar between different age groups. Although, none of the study subjects had malignant changes, but due to high prevalence of high risk HPV infection and other associated risk factors, these subjects might be at an elevated risk of developing cervical cancer. Regular follow-up of these patients who were detected HPV positive are required to screen for cervical malignancy. |
Full Text from ScienceDirect